what is considered glp 1 microdose a of a GLP1? , #glp #glp1 #longevity #weightloss #semaglutide THE PCCA BLOG | Microdosing

Weight gain during pregnancy: reexamining the guidelines

It is used in metabolic signaling research, energy homeostasis studies, and multi-hormonal pathway investigations

This was a randomized, head-to-head comparison that enrolled 751 individuals and found those who took tirzepatide lost 20% of their body weight, about 50 pounds on average, while those on semaglutide lost 14% of their body weight, or about 33 pounds on average

Orally deliverable nanoformulation of liraglutide against type 2 diabetic rat model

Retatrutide is among an emerging generation of weight loss drugs called GLP-3 agonists

In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population